ReviewBiotechnology reports (Amsterdam, Netherlands)2020
Plants against
Review in Biotechnology reports (Amsterdam, Netherlands), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed.
- Rech. f. & Esfand as adjunctive therapy for eradication: a randomized controlled trial.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2025Trial
- New insight on the assessment of potassium silicate on pharmaceutical, morphological, and elemental status of Ficus carica: in vitro.BMC research notes · 2026Article
- Extracts from Plectranthus asirensis and Premna resinosa inhibit Helicobacter pylori-induced epithelial cell damage, DNA double-strand breaks and inflammation.Gut pathogens · 2025Article
- Therapeutic Potential of OzonatedPharmaceuticals (Basel, Switzerland) · 2025Article
- Anti-urease therapy: a targeted approach to mitigating antibiotic resistance in Helicobacter pylori while preserving the gut microflora.Gut pathogens · 2025Review
- Therapeutic advances and future directions inFrontiers in microbiology · 2025Review
- TheAdvanced biomedical research · 2025Article
- Comparative Assessment of the Anti-Cells · 2024Article
- Article
- Influence of Source Materials, Concentration, Gastric Digestion, and Encapsulation on the Bioactive Response of Brassicaceae-Derived Samples againstMicroorganisms · 2023Article
- Promising anti-Pharmaceutical biology · 2023Article
- Study of the Effect of Baicalin fromInternational journal of molecular sciences · 2023Article
- Savory, Oregano and Thyme Essential Oil Mixture (HerbELICOMolecules (Basel, Switzerland) · 2023Article
- Gastroprotective and anti-Helicobacter pylori potentials of essential oils from the oleoresins of Araucaria bidwillii and Araucaria heterophylla.Inflammopharmacology · 2023Article
- Antioxidant, Anti-Inflammatory, and Antibacterial Properties of anAntioxidants (Basel, Switzerland) · 2022Article
- Can natural products modulate cytokine storm in SARS-CoV2 patients?Biotechnology reports (Amsterdam, Netherlands) · 2022Review
- Biochemical and pharmacological prospects ofHeliyon · 2022Article
- In Vitro Activity of the Arylaminoartemisinin GC012 againstPathogens (Basel, Switzerland) · 2022Article
- An Anaerobic Environment Drives the Harboring ofBiology · 2022Article
- Preparation, urease inhibition mechanisms, and anti-Current research in microbial sciences · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Worldwide,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.